These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34939678)

  • 1. Interleukin 10 and transforming growth factor-beta 1 plasma levels in atopic dogs before and during immunotherapy.
    Martini F; Rostaher A; Favrot C; Fischer N
    Vet Rec; 2022 Jun; 190(12):e1270. PubMed ID: 34939678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
    Fischer NM; Rostaher A; Favrot C
    Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.
    Fennis EEM; van Damme CMM; Schlotter YM; Sinke JD; Leistra MHG; Bartels RT; Broere F
    Vet Dermatol; 2022 Aug; 33(4):321-e75. PubMed ID: 35635279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study.
    Colombo S; Hill PB; Shaw DJ; Thoday KL
    Vet Dermatol; 2005 Jun; 16(3):162-70. PubMed ID: 15960629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
    Mueller RS; Veir J; Fieseler KV; Dow SW
    Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of short-term combination of intralymphatic allergen immunotherapy and lokivetmab treatment in canine atopic dermatitis: A double-blinded, controlled, randomised study.
    van Amersfort K; Vernooij JCM; van der Lee A
    Vet Dermatol; 2023 Oct; 34(5):373-384. PubMed ID: 37186491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis.
    Kawano K; Mizuno T
    Vet Dermatol; 2017 Dec; 28(6):583-e141. PubMed ID: 28776792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.
    Griffin CE; Hillier A
    Vet Immunol Immunopathol; 2001 Sep; 81(3-4):363-83. PubMed ID: 11553398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of immunotherapy for canine atopic dermatitis: a review.
    DeBoer DJ
    Vet Dermatol; 2017 Feb; 28(1):25-e6. PubMed ID: 28133873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.
    Zhong H; Deng X; Song Z; Darsow U; Chen W; Chen S; Luo N; Hao F
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1318-24. PubMed ID: 25376542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of primary care practitioners' referral habits and recommendations of allergen-specific immunotherapy for canine and feline patients with atopic dermatitis.
    Flanagan S; Schick A; Lewis TP; Chu Tater K; Rishniw M
    Vet Dermatol; 2021 Apr; 32(2):106-e21. PubMed ID: 33275300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the efficacy rate and time-to-efficacy of subcutaneous immunotherapy in dogs with atopic dermatitis.
    Tham HL; Olivry T
    Vet Dermatol; 2022 Apr; 33(2):155-e44. PubMed ID: 34883529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis].
    Fischer N; Rostaher A; Favrot C
    Schweiz Arch Tierheilkd; 2016 Sep; 158(9):646-652. PubMed ID: 27655164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis.
    Timm K; Mueller RS; Nett-Mettler CS
    Vet Dermatol; 2018 Apr; 29(2):123-e49. PubMed ID: 29327474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-specific immunotherapy in dogs with atopic dermatitis: is owner compliance the main success-limiting factor?
    Ramió-Lluch L; Brazís P; Ferrer L; Puigdemont A
    Vet Rec; 2020 Dec; 187(12):493. PubMed ID: 33082241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy.
    Colombo S; Hill PB; Shaw DJ; Thoday KL
    Vet Rec; 2007 Jun; 160(25):861-4. PubMed ID: 17586789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised, double-blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs.
    Mueller RS; Zablotski Y; Baumann K; Boehm T; Kasper B; Klinger C; Monke M; Udraite-Vovk L; Weitzer T; Gedon NKY
    Vet Dermatol; 2023 Apr; 34(2):91-98. PubMed ID: 36424528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of allergen immunotherapy, a successful therapy for canine atopic dermatitis and feline atopic skin syndrome.
    Mueller RS
    J Am Vet Med Assoc; 2023 Jun; 261(S1):S30-S35. PubMed ID: 36940185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis.
    Plant JD; Neradilek MB
    BMC Vet Res; 2017 Jan; 13(1):4. PubMed ID: 28056956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.